Zeneus Pharma clinical trials
Acquired by Teva Pharmaceutical Industries, Ltd., Oct 14, 2011 · source ↗
The registry lists 2 studies whose lead sponsor is Zeneus Pharma. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 8, 2005.
- 2studies on the registry
- 0open to participants now
Before and after it joined Teva Pharmaceutical Industries, Ltd.
- First submitted before Zeneus Pharma became part of Teva Pharmaceutical Industries, Ltd.
- 2
- First submitted after Zeneus Pharma became part of Teva Pharmaceutical Industries, Ltd.
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
What it is testing
The drugs Zeneus Pharma’s studies test, most studies first; none is open now — 6 drugs with a page of their own. Each count opens the studies in search.
Studies, none open
All 2 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
- Status unknown or other2100%
Registry sponsor names on this page
- Zeneus Pharma2 studies
Something wrong with this grouping? Tell us on the Teva Pharmaceutical Industries, Ltd. page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All Teva Pharmaceutical Industries, Ltd. studies →
- Myocet, Docetaxel & Trastuzumab as 1st Line Treatment of Patients With HER-2/Neu Positive Metastatic Breast CancerStatus unknownNCT00250874Phase 2
Sponsor listed in the registry: Zeneus Pharma · First submitted before Zeneus Pharma became part of Teva Pharmaceutical Industries, Ltd.
- Open Label, Single Arm, Phase II Study Using R-COMP in Elderly Patients With Aggressive NHL.Status unknownNCT00244127Phase 2
Sponsor listed in the registry: Zeneus Pharma · First submitted before Zeneus Pharma became part of Teva Pharmaceutical Industries, Ltd.